Overview


Preterm birth (also known as neonatal birth) is when the baby is born before 37 weeks gestation. For the first four weeks, special care is given to premature babies. Premature babies often have health issues such as difficulty breathing or weight gain. They need intensive medical attention and a prompt diagnosis. Preterm babies, also known as preemies, can be born with mental and physical disabilities. Preterm labor can be caused by many reasons. Preterm birth refers to a premature birth that occurs before the 37-week mark of gestation. Preterm birth is also known as premature birth. It refers to a baby born at less than 37 weeks gestational. Preemies and prees are also known as premature babies. Preterm birth is a birth that occurs at 37 weeks of gestational age. Full-term delivery takes place at 40 weeks. Extreme preterm is a birth that occurs less than 28 weeks. Very early preterm births occur between 32 and 36 weeks gestation. Late preterm births are between 34 and 36 weeks gestation. These babies are also called premature babies, preemies, or premises. Although there are a few risk factors that could increase preterm birth rates, preterm labor can also be observed in healthy pregnancies with no risk factors. Preterm birth diagnostic kits are used to detect preterm labor and possibly premature membrane rupture. Preterm birth diagnosis can also be done by ultrasound, uterine monitoring, and pelvic examination.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Preterm Birth Diagnostic Test Kits Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Preterm Birth Diagnostic Test Kits Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Abbott
  • Creative Diagnostics
  • Clinical Innovations
  • Hologic
  • IQ Products
  • Qiagen
  • Medixbiochemica
  • Biosynex
  • CooperSurgical Inc
  • Sera Prognostics
  • Stryker Corporation

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • Fetal Fibronectin Test Kits (fFN)
  • Placental Alpha Micro-Globulin-1 Test Kits (PAMG-1)
  • Insulin Like Growth Factor Binding Protein-1 Test Kits (IGFBP-1)
  • Others

By Sample Type

  • Blood Sample
  • Urine Sample
  • Vaginal Discharge Sample

By End-User

  • Diagnostic Laboratories
  • Pediatric and Neonatal
  • Clinics
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Preterm Birth Diagnostic Test Kits Market By Product Type, By Sample Type, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping-product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Preterm Birth Diagnostic Test Kits Market Variables, Trends and Scope
    •          1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Preterm Birth Diagnostic Test Kits Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Preterm Birth Diagnostic Test Kits Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Preterm Birth Diagnostic Test Kits Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Fetal Fibronectin Test Kits (fFN)
        2. Placental Alpha Micro-globulin-1 Test Kits (PAMG-1)
        3. Insulin Like Growth Factor Binding Protein-1 Test Kits (IGFBP-1)
        4. Others

  • 8.   Preterm Birth Diagnostic Test Kits Market, By Sample Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Blood Sample
        2. Urine Sample
        3. Vaginal Discharge Sample

  • 9.   Preterm Birth Diagnostic Test Kits Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Diagnostic Laboratories
        2. Pediatric and Neonatal
        3. Clinics
        4. Others

  • 10.   North America Preterm Birth Diagnostic Test Kits Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
          3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Preterm Birth Diagnostic Test Kits Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
          3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Preterm Birth Diagnostic Test Kits Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Preterm Birth Diagnostic Test Kits Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbott
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Creative Diagnostics
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Clinical Innovations
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Hologic
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. IQ Products
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Qiagen
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Medixbiochemica
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Biosynex
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. CooperSurgical Inc
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Sera Prognostics
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
           10.4. Financial Overview
         10.5. Strategic Overview
        11. Stryker Corporation
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare
                   administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients